1. Introduction
The forecast of the European pharmaceutical market predicts a 3.9% growth between 2019 and 2024, while the global market is expected to rise by about 4.2% in the same period [
1]. For the production of pharmaceutical ingredients, intermediates, and final products, as well as for the purification and preparation of reagents, water is crucial. However, water used for pharmaceutical applications is subject to strict regulations. In the European Union, the European Pharmacopeia (Ph. Eur) determines the quality of water for pharmaceutical use as well as the processing measures.
Within the current pharmacopoeias, a distinction is made between purified water (PW) and water for injection (WFI) [
2]. PW is used for the production of medical products that are neither pyrogen-free nor sterile. Pyrogens are substances that can cause fever in humans during parenteral intake (bypassing the intestine, e.g., intravenously). WFI is water for the production of medical products, solutions and dilutions for parenteral use. Drinking water with a quality according to the respective national regulations is the raw material for both PW and WFI production [
2]. The Ph. Eur. sets limits and requirements for the quality of PW and WFI; some quality parameters are depicted in
Table 1.
PW is produced by distillation, reverse osmosis (RO) in combination with electrodeionisation (EDI), ion exchange or other suitable methods [
3]. In contrast, the Ph.Eur. significantly limits the processes that may be applied for the production of WFI. The most commonly used method for WFI generation is multi-stage pressure column distillation [
3].
Membrane distillation (MD) may be an alternative process for the generation of pharma-grade water. MD is a thermal separation process based on vapor pressure differences between the feed and the distillate sides of porous, hydrophobic membranes [
4]. When drinking water is used as a feed solution, these membranes allow the passage of water vapor only and retain suspended and dissolved matter on the retentate side; thus, the condensed product obtained is theoretically 100% pure water [
5,
6].
MD is investigated worldwide as a low-cost, energy-saving alternative to conventional separation processes such as distillation and reverse osmosis (RO). MD can be operated at a relatively low feed temperature between 50 °C and 80 °C.
Some studies [
7,
8,
9] employed newly developed single-layer and multilayer graphene-based membranes for application in membrane distillation. Xu et al. [
7] reported about graphene oxide (GO) nanolayers that were deposited on the permeate side of PVDF membranes. Generally, these membranes show an advantage for membrane distillation because of their unique water channels. Application in direct-contact membrane distillation enhanced the desalination performance due to a decrease of the vapor pressure at the permeate side. Salt rejection was improved to 99.9%. Deterioration of the permeate quality caused by membrane wetting was avoided by the properties of the GO layer. Grasso et al. [
8] prepared porous composite membranes from functionalized PVDF membranes that were coated with graphene. The generated membrane was applied in direct-contact membrane distillation (DCMD) and showed long-lasting salt rejections >99.9%. Huang et al. [
9] reported about photothermal membrane distillation (PMD) using a PTFE membrane coated with an ultrathin graphene-based film. Compared to the unmodified membrane, the transmembrane water flux of the modified PTFE membranes showed an enhancement of about 78% under solar illumination.
For the operation of MD, it is important that the dry pores are not wetted by the liquid feed, which is directly in contact with the membrane. In contrast to RO, MD is not limited by the osmotic pressure that is generated; furthermore, equipment costs are lower [
10]. As MD is operated at low temperature levels, the use of waste heat [
11] as well as solar thermal energy and geothermal energy is possible [
12,
13]. On the other hand, a disadvantage of MD is the low permeate flow compared to RO [
7]. This restriction may be overcome by the further development of graphene-based membranes.
MD processes can be categorized into four basic module configurations, which play a fundamental role in separation efficiency and processing costs: direct-contact membrane distillation (DCMD), air-gap membrane distillation (AGMD), sweeping-gas membrane distillation (SGMD), and vacuum membrane distillation (VMD), as shown in
Table 2. Furthermore, alternative configurations with low energy consumption and improved flux have been developed [
14].
There is hardly any information available on the application of MD for the generation of pharma-grade water. A study [
16] reported about the application of membrane distillation for the generation of WFI without intermediate steps. Data on the performance were not provided.
4. Discussion
4.1. Parameter Variation
Table 10 depicts the effects of the feed temperature T
F, feed volume flow F
F and cooling water flow F
K on the transmembrane distillate flux F
D during AGMD.
It is obvious that the feed temperature TF is the decisive factor to increase the transmembrane distillate flow. The increase in the feed volume flow led to a reduction in the boundary layer resistance. However, this effect was limited. The effect of the cooling water flow FK on the distillate flux was negligible.
Table 11 depicts the effects of the feed temperature T
F, feed volume flow F
F, cooling water flow F
K and applied negative pressure on the transmembrane distillate flux F
D during VMD.
Similar to what observed for AGMD, the feed temperature TF had the greatest influence on the transmembrane distillate flux during VMD, followed by the feed volume flow FF and the cooling water volume flow FK. The applied negative pressure ∆p had the smallest effect on the distillate volume flow. However, ∆p had to be kept above −0.2 bar, as the feed tank design did not allow lower values. Accordingly, the effect of negative pressure on the performance of VMD could not be predicted.
4.2. Long-Term Investigations
The long-term investigations showed that both AGMD and VMD were able to produce distillates with an electrical conductivity within the limiting values of PW.
Noticeable is the dependence of the electrical conductivity of the distillate on the conductivity of the feed during AGMD. It is assumed that an intrusion of the feed solution into the distillate cycle occurred. The intrusion of the feed was caused either by minimal defects of the sealings or by a too high pressure on the feed side of the membranes that caused mass transfer through the pores of the actually hydrophobic membranes (exceedance of the liquid entry pressure LEP). In addition, the investigations showed that a certain maximum concentration of the concentrate limited the process, as the quality of the distillate depended on it. The achievable yield of AGMD thus seems limited.
The long-term investigation of the VMD did not show a comparable behavior. The conductivity of the distillate did not increase when the concentration of the feed rose. However, VMD investigations were significantly shorter compared to AGMD ones, so the concentrate concentration did not reach a hypothetical critical value.
The achievable distillate fluxes were smaller compared to the respective fluxes measured during parameter variation. It is assumed that the reason is vapor pressure reduction due to the increasing salt concentration of the concentrate. The driving force of membrane distillation during the long-term investigations was reduced accordingly and led to the decrease of the distillate flux.
4.3. Microbiological Investigations
The total bacteria count in the distillate met the requirements of PW but not those of WFI. The measured bacteria counts were 30–40 times higher than the limit value of WFI and 250–330 times below the limit value of PW. However, neither the test plant nor the module fulfilled the demands of hygienic design, as the detachable connections in the product and distillate-contacting area were realized with screw connections.
5. Conclusions and Outlook
The investigations carried out showed that single-stage MD is suitable for the production of pharmaceutical-grade water. The generated distillate reached the claims of Ph. Eur. for PW regarding the electric conductivity and the total bacteria count.
The feed temperature was the decisive factor for the performance of both AGMD and VMD configurations. All other factors played a minor role. VMD showed no significant increase in transmembrane distillate flow with an applied vacuum. The main reason for this behavior is the limited negative pressure on the distillate side that could be achieved in the test facility. Future studies of VMD should therefore be carried out below −0.2 bar.
Future studies must also provide information on whether MD is comparable to distillation and membrane-assisted processes in terms of yield and specific energy demands. The decisive factor for this is the decoupling of the quality of the distillate from that of the feed.
In addition to the necessary technical investigations, the approval of the legislator is crucial for the establishment of MD as a possible alternative to distillation and cold production by RO in a strictly regulated market. Then, the decision of pharmaceutical manufacturers to use MD will depend on the strict adherence to operational safety. This also includes the approval of FDA or other institutions for any kind of material used in the plant.
Further applications of membrane distillation in the field of ultrapure water generation seem to be promising for the treatment of water for hydrogen production. The electrolysis used for water splitting requires a fully de-salted and softened feed water. Hygienic requirements similar to those of the pharmaceutical industry do not exist. Excess heat from the electrolysis plant can be used to heat the feed water.